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in the oral mucosa of patients infected with
human immunodeficiency virusKishore Shetty a,*, Amit Chattopadhyay b, Janet Leigh ca University of Texas Health Sciences Center, Medically Complex Patient Clinic,
6516 M.D. Anderson Blvd., Suite 475, Department of Restorat, Houston, TX 77030, USA
b Department of Dental Informatics, Temple University School of Dentistry, Philadelphia, USA
c Department of General Dentistry, LSU Health Sciences Center, Louisiana, USAReceived 28 July 2005; accepted 29 July 2005Summary Recent studies have shown an increased risk of oral warts in HIV+ indi-
viduals despite treatment with highly active antiretroviral therapy (HAART). Human
papilloma virus (HPV) infection has attracted a great deal of attention, not just
because of the difficulty of managing oral warts but also because of the oncogenic
potential of certain strains, in particular HPV-16 and -18, which have been detected
in 20–30% of oral squamous cell carcinomas. Between 1999 and 2004, DNA extrac-
tion was performed using a multiplex PCR reaction to detect and type HPV in 12 HIV-
positive adult with a clinicopathologic diagnosis of Oral Warts. HPV was detected in
11 of the 12 orals warts. HPV-32 was present in all subjects, whereas only one sub-
ject had a co-infection of HPV-32 and -7. Future studies should examine the specific
roles of these specific HPV types and whether a potential link exists for oral prema-
lignant lesions.c 2005 Elsevier Ltd. All rights reserved.
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dIntroduction
Papilloma viruses are small (55 nm, 8 kb), double-
stranded DNA viruses. Over 200 genotypes of papil-
loma viruses infect the skin and mucosal surfaces.
The human papilloma virus (HPV) is a double-helix741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
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E-mail address: kshett@lsuhsc.edu (K. Shetty).virus with about 8000 base pairs in its genome.1–4
These viruses have never been cultured in vitro
but have been characterized by molecular meth-
ods. They are classified by the molecular similarity
of their genetic material and are assigned a geno-
type number.
Papilloma virus infects the basal keratinocyte of
the epidermis, presumably through disruptions
of the skin or mucosal surface. At this location,
the virus remains latent in the cell as a circularrved.
312 K. Shetty et al.episome. As the epidermal cells differentiate and
migrate to the surface, the virus is triggered to un-
dergo replication and maturation.3,4 The process of
virus replication alters the character of the epider-
mis, resulting in cutaneous or mucosal excres-
cences known as warts.
HPVs are grouped broadly into cutaneous and
mucosal types, based on the clinical location of
the resulting lesion. Although some overlap exists,
most papilloma viruses have distinct anatomic pre-
dilections, infecting only certain epidermal sites,
such as the skin or genital mucosa. A number of
genotypes of these viruses have the potential to
transform host cells and are associated with epi-
dermal malignancies. The mechanism for transfor-
mation is not known, but viral DNA apparently
integrates into the genome of the host cell.
HPV has been found in cervical cancer, tonsillar
cancer, and certain types of head and neck can-
cers.5 Furthermore, at least 30 of these have been
detected in the oral cavity.5–8 The gross appear-
ance of oral warts varies greatly and often reflects
the specific HPV genotype causing the lesion.6,7 Re-
cent studies have shown an increased risk of oralFigurewarts in HIV-infected individuals despite treatment
with highly active antiretroviral therapy (HAART).
The possibility of increases in both oral and ano-
genital pathologic conditions due to the human
papilloma virus in patients infected with human
immunodeficiency virus (HIV) is of concern and is
the focus of numerous current research studies.
Oral HPV-infection occurrences have not declined
since the initiation of HAART but may have in-
creased in white HIV-infected males.8 Urban HIV-
negative homosexual men in the USA have a high
prevalence of anal infection with human papilloma
virus (HPV).9
HAART has been responsible for decreasing HIV
plasma viral loads, increasing CD4+ T lymphocyte
counts, prolonging the progression to AIDS, and
decreasing the mortality from HIV.5 HAART has also
decreased the incidence of opportunistic infec-
tions, including those of the oral cavity. For exam-
ple, the incidences of oropharyngeal candidiasis
and oral hairy leukoplakia in HIV individuals have
significantly decreased, but, in stark contrast, inci-
dence of oral warts in this population has signifi-
cantly increased. Greenspan et al. have found a1
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in San Francisco in the 1990s.10 A recent study from
Miyako Island in Japan suggested that among
healthy individuals, oral HPV infection is uncom-
mon. In this Japanese cohort, HPV-17 and HPV-12
were persistent, while HPV-16 and HPV-53 were
transient in normal oral mucosa.11 With the success
of HAART, and possible an increase in HPV occur-
rence, studied the possibility of different HPV
genotypes in oral warts of HIV+ persons. Our objec-
tive for this study was to determine and describe
the HPV types present in oral warts of HIV+ patients
and compare those to non-HIV+ persons.Materials and methods
Between 1999 and 2004, three hundred and sev-
enty-nine HIV+ adult volunteers were recruited
and evaluated at the HIV Outpatient Program
(HOP) of the Medical Center of Louisiana at New
Orleans for an ongoing longitudinal cohort study
on oral mucosal lesions. Of the 379 patients in-
fected with HIV type 1 (HIV-1) in this study, we
examined samples from 12 who had a clinicopatho-
logic diagnosis of oral warts. Lesions were catego-
rized as oral warts on the clinical presentation of
a solitary, raised cauliflower-like lesion or multiple
soft lesions on the tongue, lips, buccal mucosa, or
labial mucosa. After being clinically and histologi-
cally diagnosed, these lesions were further charac-
terized as having one of three distinct levels of
viral activity based on the presence of parakerato-
sis, koilocytosis, and gross granules in the granular
layer and the top one-third of the spinous layer.
Tissue samples were collected by elliptical
biopsy after local anesthesia with 2% lidocaine
with/without vasoconstrictor, and were dividedTable 1 Clinical, physiological, and virological characteri
Patient No. HPV type Sex Race Age (years) CD4
1 32 M W 32 401
2 7, 32 M W 43 325
3 32 M W 40 419
4 32 M B 35 365
5 32 M B 34 20
6 32 M B 44 159
7 32 M B 39 247
8 32 F B 43 106
9 32 M B 33 246
10 32 M B 48 41
11 32 M W 44 759
12 Not-type able M W 43 432into three longitudinal fragments: one for histopa-
thological analysis, another for HPV detection and
typing, and the third was maintained in liquid
nitrogen.
HPV DNA detection: DNA extraction was per-
formed using a multiplex PCR reaction containing
HPV L1-consensus primers (PGMY09/11) and b-glo-
bin primers (GH20/PC04) (supplied by Roche
Molecular Systems) to test for sample adequacy
according to Roche protocol as described in an-
other study.12 Quality assurance and contamination
avoidance were performed by using separate areas
for DNA extraction, PCR set-up, and gel electro-
phoresis to avoid PCR-contamination. For each
PCR run, a master PCR mix was prepared, and
water blanks were inserted after every fourth
sample. After amplification, products were ana-
lyzed by electrophoresis, and the size of the band
obtained was compared with the molecular weight
standard. DNA extracted from cultured SiHa cells
was used as an HPV+ control. PCR products after
40 amplifications were considered positive for
HPV if the products demonstrated the 254 base-
pair b-globin band and the 450 base-pair HPV
band (Fig. 1).Results
Of the 12 patients in the experimental group, one
was an African American woman; 11 were Cauca-
sian men; 9 received HAART. The mean CD4 cell
count was 281 (±210) cells/lL. Clinical, physiologi-
cal, and virological characteristics of the volun-
teers who were HPV+ in oral wart lesions are
shown in Table 1. Overall, HPV was detected in
11 of the 12 orals warts. Two different HPV types
were found (HPV-32; HPV-7). HPV-32 was presentstics of the HIV 1 and oral-wart HPV positive patients
(cells/lL) HIV-1 viral load (cp/mL) Anti-HIV therapy
<400 HAART
92,413 NONE
648 HAART
<400 HAART
1,13,183 HAART
<400 NONE
51,605 HAART
<400 HAART
1,00,103 HAART
<400 HAART
<400 HAART
<400 HAART
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infection of HPV-32 and -7.Discussion
Increased occurrences of oral warts in HIV+ per-
sons, especially after the institution of HAART have
been documented.10,13,14 HPV is associated with
several oral lesions grouped clinically as oral warts
(verruca vulgaris, squamous cell papillomas, con-
dyloma acuminata, focal epithelial hyperplasia
and also with oral leukoplakia with dysplastic
change.15–17 Oral warts can present in almost any
location in the mouth as nodular or raised lesions
that appear pink or white depending on the degree
of keratinization. Squamous papillomas occur
predominantly as solitary cauliflower-like lesions
unlike condylomas or FEH, which present as multi-
ple soft lesions that frequently coalesce into nodu-
lar tissue masses.6–15 The histology of HPV+
mucosal epithelium shows epithelial hyperplasia
where HPV is restricted mostly to the spinous layer
of the epithelium. The connective tissue layer is
usually well vascularized without any inflammatory
changes.
HPV oral lesions have been reported in 0.4% of
the general population.18,19 All persons infected
with HPV do not develop oral lesions. HPV DNA
detection rate in individuals without any obvious
oral lesion (whether HIV+ or not) has varied widely
depending on the study population, type of sample
collected, method of DNA detection (hybridization
versus polymerase chain reaction PCR), and the
primers and specific probes utilized. In a recent
study, HPV DNA was detected in approximately
36% of HIV+ individuals compared to 6% of HIV
individuals.20
Although many strains of HPV have been de-
tected in the oral cavity,6,21 the strain most often
associated with oral warts is HPV 32.6 However,
these reports were before the advent of HAART.
All of our cases were HPV-32, with the exception
of one co-infection with HPV-7, a hitherto unre-
ported genotype in the oral cavity. HPV-7, usually
associated with benign warts in butchers,22 has
been reported to have a high degree of homology
with HPV-40, a rare type, which has been reported
in papilloma of the hard palate.23 It is possible that
HIV-1-infected patients present lesions caused by
rare or even by new HPV types, which the primer
pairs used in the present study did not detect. It
is likely that the combination with other primer
pairs would not only increase the rate of HPV
detection but might also detect other distinctHPV types. However, the omnipresence of HPV-32
in our samples suggests that this genotype is the
major force in oral warts, and its prevalence has
not changed in the post-HAART era.
HPV infection has attracted a great deal of
attention, not just because of the difficulty of
managing oral warts but also because of the onco-
genic potential of certain strains, in particular
HPV-16 and -18, which have been detected in
20–30% of oral squamous cell carcinomas.15,24
The increase in oral warts is of particular interest
in light of documented increases in cervical and
anal HPV infection in HIV-positive individuals caus-
ing genital warts and anal dysplasia.25,26 Future
studies should examine the specific roles of these
specific HPV types and whether a potential link
exists for oral premalignant lesions.References
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